Ketoacidosis at time of diagnosis of type 1 diabetes in children and adolescents: Effect of a national prevention campaign

被引:21
|
作者
Choleau, C. [1 ]
Maitre, J. [1 ,2 ,3 ]
Elie, C. [3 ,4 ]
Barat, P. [5 ]
Bertrand, A. M. [6 ]
de Kerdanet, M. [7 ]
Le Tallec, C. [8 ]
Nicolino, M. [9 ]
Tubiana-Rufi, N. [10 ]
Levy-Marchal, C. [11 ]
Cahane, M. [1 ]
Robert, J. -J. [1 ,2 ,3 ]
机构
[1] AJD, F-75013 Paris, France
[2] Hop Necker Enfants Malad, AP HP, Diabet Enfant & Adolescent, F-75015 Paris, France
[3] Univ Paris 05, Sorbonne Paris Cite, F-75006 Paris, France
[4] Hop Necker Enfants Malad, AP HP, Unite Rech Clin Paris Ctr, F-75015 Paris, France
[5] CHU Bordeaux, Endocrinol & Diabetol Pediat, F-33076 Bordeaux, France
[6] CHU Jean Minjoz, Med Pediat, Unite Endocrinol Diabetol Pediat, F-25030 Besancon, France
[7] CHU Rennes, Hop Sud, Endocrinol & Diabetol Pediat, F-35000 Rennes, France
[8] CHU Toulouse, Pole Pediat, Diabetol Pediat, F-31059 Toulouse 9, France
[9] Univ Lyon, Hop Femme Mere Enfant, Endocrinol Pediat, F-69677 Lyon, France
[10] Univ Paris Diderot, Hop Robert Debre, AP HP, Endocrinol & Diabetol Pediat,Sorbonne Paris Cite, F-75019 Paris, France
[11] Hop Robert Debre, Inserm CIC EC 05, F-75019 Paris, France
来源
ARCHIVES DE PEDIATRIE | 2015年 / 22卷 / 04期
关键词
CONSENSUS STATEMENT; RISK-FACTORS; ONSET; AGE; FREQUENCY; MELLITUS; YOUNGER; STILL;
D O I
10.1016/j.arcped.2014.11.001
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The aim of the study was to evaluate, after the first year of a national information campaign, the effect on the frequency and severity of diabetic ketoacidosis (DKA) at diagnosis of type 1 diabetes (T1D) in children and adolescents in France. The following data were collected during a 2-year period in people younger than 15 years of age at diagnosis of T1D, in 146 pediatric centers: age, sex, duration of symptoms, patient's previous care, clinical and biological signs, and family history of T1D. DKA was defined as pH < 7.30 or bicarbonate < 15 mmol/L, severe DKA as pH < 7.10 or bicarbonate < 5 mmol/L. During the 2nd year, an information campaign targeting health professionals and families was launched with the objective of reducing the time to diagnosis. Data were compared between the year before the campaign (year 0) and the first year of the campaign (year 1). The number of new cases of T1D was 1299 for year 0 and 1247 for year 1. Between year 0 and year 1, the rate of DKA decreased from 43.9% to 40.5% (P = 0.08), exclusively due to the decrease of severe DKA from 14.8 to 11.4% (P = 0.01). In the 0- to 5-year-old and 5- to 10-year-old age groups, the relative decrease in the rate of DKA was 13% and 15%, and 23% and 41% for severe DKA, respectively. In patients referred to the hospital by a pediatrician or who came at the family's initiative, the decrease was 34% and 7%, and 39% and 32% for severe DKA, respectively. No change was observed in the 10- to 15-year-old group or in those children who were referred by a general practitioner. In multivariate analyses, a higher DKA rate was associated with the young age of the child (< 5 years), being hospitalized at the parents' initiative rather than being referred by a doctor, and the absence of a family history of T1D. A higher rate of severe DKA was associated with these last two factors but not with the child's age. The frequency of DKA at diagnosis of type 1 diabetes remains high in children and adolescents, but the first year of an information campaign decreased it. The results have also helped better define the strategy and targets of the continuing prevention campaign, to more efficiently reduce the morbidity and mortality of T1D at diagnosis in children and adolescents in France. (C) 2014 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:343 / 351
页数:9
相关论文
共 50 条
  • [1] Ketoacidosis at diagnosis of type 1 diabetes in French children and adolescents
    Choleau, C.
    Maitre, J.
    Pierucci, A. Filipovic
    Elie, C.
    Barat, P.
    Bertrand, A. -M.
    de Kerdanet, M.
    Letallec, C.
    Levy-Marchal, C.
    Nicolino, M.
    Tubiana-Rufi, N.
    Cahane, M.
    Robert, J. J.
    DIABETES & METABOLISM, 2014, 40 (02) : 137 - 142
  • [2] Factors associated with ketoacidosis at diagnosis of type 1 diabetes in children and adolescents
    Latifa, B.
    Zahra, N. Fatima
    Fatimazahra, Z.
    Hajar, C.
    Siham, R.
    Hanane, L.
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 260 - 260
  • [3] Ketoacidosis at diagnosis of type 1 diabetes in children and adolescents: Frequency and clinical characteristics
    Onyiriuka A.N.
    Ifebi E.
    Journal of Diabetes & Metabolic Disorders, 12 (1):
  • [4] Significant reduction of ketoacidosis at diabetes onset in children and adolescents with type 1 diabetes-The Stuttgart Diabetes Awareness Campaign, Germany
    Holder, Martin
    Ehehalt, Stefan
    PEDIATRIC DIABETES, 2020, 21 (07) : 1227 - 1231
  • [5] Diabetic ketoacidosis in type 1 diabetes mellitus in children and adolescents
    Kim, Minsun
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2024, 67 (05): : 335 - 341
  • [6] The treatment and prevention of diabetic ketoacidosis in children and adolescents with type I diabetes mellitus
    Kaufman, FR
    Halvorson, M
    PEDIATRIC ANNALS, 1999, 28 (09): : 576 - +
  • [7] Age-Related Differences in the Frequency of Ketoacidosis at Diagnosis of Type 1 Diabetes in Children and Adolescents
    Hekkala, Anne
    Reunanen, Antti
    Koski, Matti
    Knip, Mikael
    Veijola, Riitta
    DIABETES CARE, 2010, 33 (07) : 1500 - 1502
  • [8] Diabetic Ketoacidosis at the Time of Diagnosis of Type 1 Diabetes in Children: Insights From TRIGR
    Nakhla, Meranda
    Cuthbertson, David
    Becker, Dorothy J.
    Pacaud, Daniele
    Ludvigsson, Johnny
    Knip, Mikael
    Legault, Laurent
    JAMA PEDIATRICS, 2021, 175 (05) : 518 - 520
  • [9] Factors associated to ketoacidosis at diagnosis of type 1 diabetes in children
    Blanc, N
    Lucidarme, N
    Tubiana-Rufi, N
    ARCHIVES DE PEDIATRIE, 2003, 10 (04): : 320 - 325
  • [10] Management of Diabetic Ketoacidosis in Children and Adolescents with Type 1 Diabetes Mellitus
    Luz Castellanos
    Marwa Tuffaha
    Dorit Koren
    Lynne L. Levitsky
    Pediatric Drugs, 2020, 22 : 357 - 367